Hexter Joshua
Reporting owner on Forms 3, 4 and 5, CIK 1573235.
Hexter Joshua reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. CIK 1176309 | officer (COO & CBO) | 2 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. Common Stock | 2026-10-01 | S sold | -30,000 | $4.511 | 1,328,130 | Form 4 |
| ORAMED PHARMACEUTICALS INC. Common Stock | 2026-09-24 | A granted | +75,455 | 1,148,839 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Common Stock | 2026-09-24 | A granted | +209,291 | 1,358,130 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -50,000 | 0 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -50,000 | 0 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -36,000 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001213900-26-106530 | ORAMED PHARMACEUTICALS INC. | 2026-10-02 | ||
| Form 4 0001213900-26-103538 | ORAMED PHARMACEUTICALS INC. | 2026-09-25 |